RE:RE:RE:RE:Every month cash disclosure Yeehaw1 wrote: Well Christina said she watches stockhouse board hope she watches this and also see the concern that how 2022 cash will look like in 2023 once a major drop in revs from the covid testing. Number speaks .... Q1 2022 and Q2 2022 and ofcouse if somehow they manage to able the cash for 2022 then you must have something keep you going with the increasing cash in 2023 otherwise do not blame on manipulation of stock by the institutions.
hope long understands this.
I'm not quite sure what you're trying say in the above paragraph as it's a bit incoherent. A little too much alcohol this afternoon? You're even slurring your words in your writing.
Marshall just stated in the Discord that Covid testing is going strong. Yes, Covid testing would be expected to dwindle over time, so I'm not sure what your point is. They do covid testing for the movie industry and leading into the summer the movie industry has less productions going on. We already know that, so revenue will be less for covid testing in Q2. No surprises there.
Again, you seem to be missing the point of the covid testing for this company. Covid testing was an opportunity that this company had to turn an unfortunate world event into something that was helpful for the population and at the same time make extra cash on the side... and they have certainly done that in spades. It has never been a vertical that the company is leaning on as their main source of revenue for the life of the company. Something you seem to be alluding to in your paragraph. Relax, Marshall and his team are steps ahead of you in thinking and clearly have a very well thought out plan. You are aware that Marshal did discuss their choice of verticals in the discord and also mentioned that they had many verticals to choose from and they chose what they believe are the best for their company and production of revenue.
Once again, Covid revenues have been a bonus and has boosted this company years ahead of where it would have been if not for that covid revenue. I would think Medi-call is expected to replace that revenue, as are other verticals and aquistitions. And those will far exceed covid testing revenues as this company grows.
Medi-Call alone will probably bring in more revenue then the covid testing over time as it ramps up and expands. This will become a consistant and predicatable revenue stream which investors and institutions love to hear. Medi-Call will have a client base right out of the gates so it will immediatey be generating revenue for the company.
You seem to be lost in not seeing all the other verticals DM is building and the revenue potential. For all you know covid testing may continue into 2024 or longer. There's always the possibility of a new variant. After all there are a lot of unvaccinated people in the world which the virus can infect and live long enough to mutate. That's a lot tougher for a virus to do in vaccinated people.